Link between AstraZeneca and blood clots confirmed. Early diagnosis important

Blood clots can be a very rare side effect, but the overall benefit-risk remains positive, the European Medicines Agency said.

AstraZeneca vaccines against Covid-19AstraZeneca vaccines against Covid-19 (Source: AP/TASR)

Unusual blood clots with low blood platelets should be listed as a very rare side effect of the AstraZeneca vaccine, the safety committee of the European Medicines Agency (EMA) has concluded.

The agency has checked 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database, as of March 22, 2021.

One of the explanations for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one sometimes seen in patients treated with heparin, according to EMA.

“The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing Covid-19 outweigh the risks of side effects,” EMA reported.

Still, people who have received the vaccine should seek medical assistance immediately if they develop symptoms related to a combination of blood clots and low blood platelets.

Checking symptoms

EMA has reminded healthcare professionals and people receiving the vaccine, to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets, occurring within two weeks of vaccination.

Most cases reported have occurred in women under 60 years of age within 14 days after vaccination so far. Based on currently available evidence, specific risk factors have not been confirmed.

One explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one sometimes seen in patients treated with heparin, according to EMA.

The agency will continue monitoring the vaccine’s safety and effectiveness.

Slovakia to monitor the situation

The State Institute for Drug Control (ŠÚKL) respects the EMA statement and is ready to monitor the safety of the AstraZeneca vaccine as well.

State controllers will not decide on Sputnik V. They do not have enough data Read more 

Similarly to the European authority, the institute stressed the need for early diagnosis and treatment, claiming that it helps prevent more serious complications, the SITA newswire reported.

ŠÚKL has meanwhile contacted the Health Ministry, ready to discuss a vaccination strategy in Slovakia.

The topic will be discussed by a group of epidemiological and immunology experts, who are supposed to meet on April 8, Health Ministry spokesperson Zuzana Eliášová said, as reported by the TASR newswire.

Read more about the coronavirus developments in Slovakia:

Get daily Slovak news directly to your inbox

Theme: Coronavirus

Read more articles by the topic

Top stories

Health Minister Marek Krajčí and PM Igor Matovič shaking hands in front of cargo plane with Sputnik V supplies on March 1.

Sputnik V was checked by a lab after ex-minister Krajčí’s request

Both the ministry and the drug control authority were notified about the lacking registration but had no objections, said head of the Biomedical Research Centre.

4 h
Health Minister Marek Krajčí (left) and PM Igor Matovič (both OĽaNO) welcome the first Sputnik vaccine doses in Slovakia.

Chief hygienist and scientists back the Slovak medicines agency

General Prosecutor’s office has received a motion to investigate the controversy surrounding vaccines.

24 h
Igor Matovič at the April 9 press conference.

Russia’s vaccine diplomacy received a blow

Several foreign media have reported on the recent dispute over the Russian vaccine Sputnik V in Slovakia.

4 h
PM Igor Matovič talked about the purchase of 2 million Sputnik V vaccines in mid-February.

Matovič fell into a trap carefully staged by Russia

The former prime minister committed a diplomatic faux pas and disregarded the Slovak national interest, says foreign policy analyst Pavel Havlíček.

23 h